rosiglitazone (Avandia)

DRUG2 trials

Sponsors

National Center for Research Resources (NCRR), Northwell Health

Conditions

Focal GlomerulosclerosisHIV InfectionsInsulin Resistance

Phase 1

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

CompletedNCT00193648

Northwell HealthFocal Glomerulosclerosis

Start: 2005-07-31End: 2007-10-31Updated: 2007-10-22

Unknown Phase

Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution

CompletedNCT00025753

National Center for Research Resources (NCRR)HIV Infections, Insulin Resistance

Updated: 2005-06-24